6491 — Pegavision Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual cashflow statement for Pegavision, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	845	1,444	1,817	1,979	2,133
Depreciation
Amortisation
Non-Cash Items	19.6	31.4	48.2	119	-20.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-279	501	-751	-2,235	1,361
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,194	2,633	2,047	799	4,201
Capital Expenditures	-716	-1,853	-1,429	-1,284	-3,453
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3.1	3.96	0.935	-2,113	977
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-719	-1,849	-1,429	-3,398	-2,476
Financing Cash Flow Items	-0.117	22.4	23	0.03	-1.91
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-43.8	-172	-623	2,268	-1,229
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	433	603	-2.85	-346	502